ClinicaliQ Trial Snapshot
- Stopping Aminosalicylate Therapy in Inactive Crohn’s Disease — Active Not Recruiting • Phase IV • Gastroenterology • NCT03261206.
- Stopping 5-ASA medication in inactive Crohn's disease works as well as continuing it.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this study is to assess whether withdrawal of aminosalicylate (5-ASA) is non-inferior to continuation of 5-ASA therapy in Crohn's disease (CD) subjects in remission. Conditions: Crohn Disease, Remission Interventions: 5-ASA Withdrawal Lead Sponsor: Alimentiv Inc. Planned Enrollment: 334 participants